Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC28 protein kinase regulatory subunit 1B pseudogene 5 (CKS1BP5) is classified as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not encode functional proteins. CKS1BP5, like other pseudogenes, may be transcribed and could, in principle, play a role in gene regulation via noncoding RNA mechanisms such as acting as a microRNA decoy or producing regulatory RNAs, but there is no published evidence for specific biological or clinical relevance for CKS1BP5 itself[1][3][4].
None applicable (No direct drug targeting mechanism for pseudogenes such as CKS1BP5[1][3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC28 protein kinase regulatory subunit 1B pseudogene 5 (CKS1BP5).